Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	ARG250	36
Overall Study	STARTED	ARG300	38
Overall Study	STARTED	ARG350	32
Overall Study	STARTED	Heparin	34
Overall Study	COMPLETED	ARG250	36
Overall Study	COMPLETED	ARG300	38
Overall Study	COMPLETED	ARG350	31
Overall Study	COMPLETED	Heparin	33
Overall Study	NOT COMPLETED	ARG250	0
Overall Study	NOT COMPLETED	ARG300	0
Overall Study	NOT COMPLETED	ARG350	1
Overall Study	NOT COMPLETED	Heparin	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00508924/flow